NCT05934032
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +13 more
- Locations
-
- University Hospital Cologne Cologne, Germany
Clinical trial condition
Neoplasms by Site
Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.
140 public trials
44 recruiting studies
Neoplasms by Site trial results
NCT04949282
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +19 more
- Locations
-
- Hospital Clínico Universitario de Santiago Santiago de Compostela, A Coruña, Spain
- Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
- Hospital Unviersitari Son Espases Palma de Mallorca, Balearic Islands, Spain
- Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
NCT05252078
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Jiangxi Cancer Hospital Nanchang, Jiangxi, China
NCT02701244
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +11 more
- Locations
-
- Allegheny General Hospital Pittsburgh, Pennsylvania, United States
- Mary Washington Hospital Fredericksburg, Virginia, United States
- Swedish Cancer Institute Seattle, Washington, United States
Not yet recruiting
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
NCT07162883
- Conditions
- Bronchial Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
- Locations
-
Not specified
Not yet recruiting
Investigation of the Performance of the Medical Device Dermalyser in Determining Melanoma Thickness Based on Dermoscopy Images
NCT06788665
- Conditions
- Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
- Locations
-
- Department of Dermatology and Venereology Sahlgrenska University Hospital, Gröna stråket 16 Gothenburg, Sweden
Active, not recruiting
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
NCT04964934
- Conditions
- Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Hot Springs, Arkansas, United States
- Research Site Little Rock, Arkansas, United States
- Research Site Long Beach, California, United States
NCT05941897
- Conditions
- Advanced or Metastatic NSCLC, Bronchial Diseases, Bronchial Neoplasms, +9 more
- Locations
-
- Research Site Moscow, Russia
- Research Site Moscow, Russia
- Research Site Moscow, Russia
- Research Site Moscow, Russia
Active, not recruiting
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- University of California San Diego San Diego, California, United States
- University of California San Francisco San Francisco, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
Active, not recruiting
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
NCT04572451
- Conditions
- Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States